All News

CAR-X

FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
29 November 2023
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
FDA investigates T cell malignancy
Arcellx and Gilead’s Kite Further Expands Their Strategic Partnership
16 November 2023
Arcellx and Gilead’s Kite Further Expands Their Strategic Partnership
Kite has decided to exercise
20 Years of Advanced Therapies with Claudia Zylberberg: a Community Sense of Time & Value for the Industry
31 October 2023
20 Years of Advanced Therapies with Claudia Zylberberg: a Community Sense of Time & Value for the Industry
Claudia Zylberberg, Founder/Chair of Board/Senior
20 Years of Advanced Therapies with Pascal Touchon: a Perennial Story of Resilience, to Reality
23 October 2023
20 Years of Advanced Therapies with Pascal Touchon: a Perennial Story of Resilience, to Reality
Pascal Touchon, President and CEO
POPULAR NEWS ITEMS
Image
4 December 2023

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image
6 December 2023

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image
5 December 2023

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome

Broken String Bioscience Closes $15M Series A Funding Round
19 September 2023
Broken String Bioscience Closes $15M Series A Funding Round
Broken String Biosciences has announced
FDA Delays the Review of Iovance’s BLA Treatment of Advanced Melanoma
15 September 2023
FDA Delays the Review of Iovance’s BLA Treatment of Advanced Melanoma
The FDA has notified Iovance
CancerVAX Introduces a Universal CAR-T Cell Platform in its Expanded Development Pipeline
14 September 2023
CancerVAX Introduces a Universal CAR-T Cell Platform in its Expanded Development Pipeline
CancerVAX has expanded its development
Phacilitate Announces Lifetime Achievement Award Winner for 2024, and Opens Entries for the Second Advanced Therapies Awards 
13 September 2023
Phacilitate Announces Lifetime Achievement Award Winner for 2024, and Opens Entries for the Second Advanced Therapies Awards 
Following a show-stopping and emotional
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome